Biochemical Reagent
-
BA6491 GNE-6893Summary: GNE-6893 is an orally effective inhibitor. -
BA6492 HPK1-IN-19Summary: An inhibitor of hematopoietic progenitor cell kinase 1.
-
BA6493 ZunsemetinibSummary: Zunsemetinib (CDD-450) is an orally active mitogen-activated protein kinase-activated protein kinase 2 pathway inhibitor.
-
BA6494 MK2-IN-3Summary: MK2-IN-3 is a potent and selective inhibitor.
-
BA6495 MMI-0100Summary: MMI-0100 is a cell-permeable peptide inhibitor that inhibits mitogen-activated protein kinase-activated protein kinase II.
-
BA6496 NST-628Summary: NST-628 is a MAPK pathway molecular gel with blood-brain barrier permeability that inhibits phosphorylation and activation.
-
BA6497 MS432Summary: MS432 is an innovative, highly selective, degradation agent based on PD0325901 and ligands.
-
BA6498 TrametiglueSummary: A derivative.
-
BA6500 MS934Summary: MS934 is a new and improved degradation agent for VHL recruitment.
-
BA6502 GSK1790627Summary: GSK1790627 is an N-deacetyl metabolite.